APOLLO Phase 3 Trial Methodology Published in BMC Neurology

APOLLO Phase 3 Trial Methodology Published in BMC Neurology

A paper describing the rationale and design of the APOLLO Phase 3 study was published in BMC Neurology. APOLLO was a randomized, double-blind, placebo-controlled, global study evaluating the efficacy and safety of patisiran, an investigational RNAi therapeutic, in patients with hATTR amyloidosis with polyneuropathy.

Read the paper in BMC Neurology



SIGN UP FOR PATIENT CONNECT

Receive updates on our investigational therapies and clinical trials.